Tilray Medical wins INFARMED approval for in-house EU-GMP quality testing at Portugal facility

Bitget2026/10/13 11:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Portugal’s INFARMED cleared Tilray’s Cantanhede EU-GMP facility to run microbiological, chemical, physical quality tests in-house.
Move brings batch-release testing off third parties, aiming to cut costs, shorten timelines, accelerate product releases into regulated markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610130700PRIMZONEFULLFEED9844214) on October 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tilray Medical wins INFARMED approval for in-house EU-GMP quality testing at Portugal facility

You may also like

Crypto prices